Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety

Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens

Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy

Creative Diagnostics Launches New P53 and Tp53 Antibodies for Cancer Research

Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness

Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues

Macrophage Migration Inhibitory Factor Reagents for Research Applications

Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing.

Creative Diagnostics announced the launch of a range of new reagents for the analysis of Dapsone in food, including Dapsone Antibodies & Antigens, Dapsone ELISA Kits, and Dapsone Screen Tests.

Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research

Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services

Creative Diagnostics Launches Carbamazepine Test Reagents

Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications

Creative Diagnostics Launches Checkerboard Assay Services

Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development

Creative Diagnostics has recently launched a series of Antimicrobial Synergy Testing Services to the reserch community.

Creative Diagnostics has announced a series of new ELISA Kits to assist researchers in studing the mechanisms of autoimmunity.

Creative Diagnostics announced the launch of its new Antimicrobial Susceptibility Testing (AST) services.

Creative Diagnostics has announced a series of new reagent solutions to assist researchers in the bioanalysis of ADCs.

Creative Diagnostics has announced the launch of new reagent solutions for herpesvirus research.

Creative Diagnostics has introduced its new qPCR Assay to the research community.

Creative Diagnostics has launched its new Single Radial Immunodiffusion Testing services for the biological industry.

Creative Diagnostics has launched a set of highly specific antibodies against FXIIIa/F13A1 for vascular diseases.

Creative Diagnostics recently introduced a series of Viral Replicon Assay services to assist researchers in identifying and studying viruses.

Creative Diagnostics announces the launch of its new line of Calprotectin Reagents to accelerate research in inflammatory diseases.

Creative Diagnostics recently introduced a new line of low endotoxin antibodies to biopharmaceutical research laboratories.

Creative Diagnostics introduced the Virus Yield Reduction Assay Service to support researchers in evaluating the antiviral activity of compounds.

Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera.

Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities.

Creative Diagnostics recently introduced the TCID50 Assay Service suitable for drug sensitivity tests, infectious units quantification, the determination of virus doses, as well as virus release studies.

Creative Diagnostics recently introduced a series of HPV vaccine development products.